Cargando…
In silico Approach for Anti-Thrombosis Drug Discovery: P2Y(1)R Structure-Based TCMs Screening
Cardiovascular diseases (CVDs), including thrombosis, which is induced by platelet aggregation, are the leading cause of mortality worldwide. The P2Y(1) receptor (P2Y(1)R) facilitates platelet aggregation and is thus an important potential anti-thrombotic drug target. The P2Y(1)R protein structure c...
Autores principales: | Yi, Fan, Sun, Le, Xu, Li-jia, Peng, Yong, Liu, Hai-bo, He, Chun-nian, Xiao, Pei-gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220089/ https://www.ncbi.nlm.nih.gov/pubmed/28119608 http://dx.doi.org/10.3389/fphar.2016.00531 |
Ejemplares similares
-
Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria
por: Wang, Yang, et al.
Publicado: (2015) -
Discovery of novel anti-tumor compounds targeting PARP-1 with induction of autophagy through in silico and in vitro screening
por: Shi, Danfeng, et al.
Publicado: (2022) -
Discovery of TCMs and derivatives against the main protease of SARS-CoV-2 via high throughput screening, ADMET analysis, and inhibition assay in vitro
por: Qi, Xinyu, et al.
Publicado: (2022) -
Editorial: Computational chemogenomics: In silico tools in pharmacological research and drug discovery
por: Sánchez-Cruz, Norberto, et al.
Publicado: (2023) -
Efficacy and safety of TCMs with anti-inflammatory effect in patients with rheumatoid arthritis: A network meta-analysis
por: Fang, Jinying, et al.
Publicado: (2023)